<!DOCTYPE HTML>
<!--
	Story by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Abstract DDW 2025 HBOT PFCD</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
		<noscript><link rel="stylesheet" href="assets/css/noscript.css" /></noscript>
	</head>
	<body class="is-preload">

		<!-- Wrapper -->
			<div id="wrapper" class="divided">

				<!-- One -->
					<section class="banner style1 orient-left content-align-left image-position-right fullscreen onload-image-fade-in onload-content-fade-right">
						<div class="content">
							<h1>An EPHA2-centered gene regulatory network associates with hyperbaric oxygen treatment response in perianal fistulizing Crohn’s disease patients </h1>
							<ul class="actions stacked">
								<li><a href="#first" class="button big wide smooth-scroll-middle">Get Started</a></li>
							</ul>
						</div>
					</section>

				<!-- Two -->
					<section class="spotlight style1 orient-right content-align-left image-position-center onscroll-image-fade-in" id="first">
						<div class="content">
							<h2 class="centered">Introduction</h2>
<p class="major">Perianal fistulizing Crohn’s disease (PFCD) is a debilitating CD complication characterized by the formation of a tract (fistula) between the anorectal mucosa and other epithelial-lined surfaces. Despite the standard multidisciplinary approach combining surgery and medical management, long-term remission rates remain low, often not exceeding 50%<sup>1</sup>. Hyperbaric oxygen therapy (HBOT) has shown benefits in PFCD as an adjunct therapy following surgical closure<sup>2</sup>. Our aim is to evaluate its mechanism for enhancing long-term remission in PFCD patients following surgery.</p>
							<ul class="actions stacked">
							</ul>
						</div>
					</section>

				<!-- Three -->
					<section class="spotlight style1 orient-left content-align-left image-position-center onscroll-image-fade-in">
						<div class="content">
							<h2 class="centered">Aim</h2>
							<p class="major">We aim to investigate the cellular representation and transcriptomic processes in fistula biopsies before and after HBOT through single-cell RNA-sequencing (scRNA-seq) and assess the differences between remitters and non-remitters.</p>
						</div>
					</section>

<!-- Four -->
<section class="spotlight style1 content-align-left onscroll-image-fade-in">
  <div class="content">
    <h2>Method</h2>
    <p class="major">
      Patients with active PFCD refractory to optimized medical therapy were included and treated with 40
      sessions of HBOT (110 minutes with 5-minute air breaks, 100% oxygen at 2.4 atmosphere) (<b>Fig. 1</b>). 
      <br><br>
      Biopsies were collected from the internal opening
      and adjacent rectal mucosa at baseline and 4
      weeks into HBOT, which fistula closure surgery
      was performed after. Biopsies were subsequently
      analyzed with scRNA-seq to find differences
      between remitters and non-remitters.<br>
      Remission was defined as combined clinical (no
      draining openings) and MRI remission (MAGNIFI-CD ≤
      6) at 26 weeks follow-up. 
    </p>
</section>

<section> 
    <div class="image" style="text-align: center;">
      <img src="images/figures/1.png" alt="Figure 1" />
    </div>
  </div>
</section>

				<!-- Five -->
					<section class="wrapper style1 align-center">
						<div class="major">
							<h2>Results</h2>
							<p>We included 10 patients (7 remitters and 3 non-remitters), from which we acquired transcriptomic data of 34,185 cells (Fig. 2A and 2B). 
At baseline, remitter-derived epithelial cells displayed a gene-regulatory network (GRN) in epithelial cells centered around EPHA2 and its downstream ephrin pathway, which disappeared at follow-up (Fig. 2C). 
Notably, the EPHA2 driven GRN was observable among remitters but not non-remitters prior to the start of treatment (Fig. 2D) whilst EPHA2 expression significantly decreased in remitters, it was unaffected in non-remitters over time (Fig. 2E). 
The EPHA2-GRN showed no significant differential expression when comparing inflamed and non-inflamed colonic biopsies from Kong et al.<sup>3</sup>, suggesting EPHA2 GRN is not related to an inflammation-dependent process (Fig. 2F).
</p>
						</div>

						<!-- Gallery -->
							<div class="gallery style2 medium lightbox onscroll-fade-in">
								<article>
									<a href="images/figures/2A.png" class="image">
										<img src="images/figures/2A.png" alt="" />
									</a>
									<div class="caption">
										<h3>Fig. 2A</h3>
										<p>UMAP of 34,185 cells across 10 patients, colored by cell type.</p>
										<ul class="actions fixed">
											<li><span class="button small">Details</span></li>
										</ul>
									</div>
								</article>
								<article>
									<a href="images/figures/2B.png" class="image">
										<img src="images/figures/2B.png" alt="" />
									</a>
									<div class="caption">
										<h3>Fig. 2B</h3>
										<p>UMAP of 34,185 cells across 10 patients, colored by timepoint and split by remission status. </p>
										<ul class="actions fixed">
											<li><span class="button small">Details</span></li>
										</ul>
									</div>
								</article>
								<article>
									<a href="images/figures/2C.png" class="image">
										<img src="images/figures/2C.png" alt="" />
									</a>
									<div class="caption">
										<h3>Fig. 2C</h3>
										<p>Chord diagram of differential cell-cell interactions of remitters at baseline and follow-up.</p>
										<ul class="actions fixed">
											<li><span class="button small">Details</span></li>
										</ul>
									</div>
								</article>
								<article>
									<a href="images/figures/2D.png" class="image">
										<img src="images/figures/2D.png" alt="" />
									</a>
									<div class="caption">
										<h3>Fig. 2D</h3>
										<p>EPHA2-centered gene regulatory network is upregulated only among remitters.</p>
										<ul class="actions fixed">
											<li><span class="button small">Details</span></li>
										</ul>
									</div>
								</article>
								<article>
									<a href="images/figures/2E.png" class="image">
										<img src="images/figures/2E.png" alt="" />
									</a>
									<div class="caption">
										<h3>Fig. 2E</h3>
										<p>EPHA2 expression indicating significant downregulated across treatment among remitters but not among non-remitters. </p>
										<ul class="actions fixed">
											<li><span class="button small">Details</span></li>
										</ul>
									</div>
								</article>
								<article>
									<a href="images/figures/2F.png" class="image">
										<img src="images/figures/2F.png" alt="" />
									</a>
									<div class="caption">
										<h3>Fig. 2F</h3>
										<p>EPHA2 expression as published by Kong et al. grouped by phenotype shows no differential expression.</p>
										<ul class="actions fixed">
											<li><span class="button small">Details</span></li>
										</ul>
									</div>
								</article>
							</div>

					</section>

				<!-- Six -->
					<section class="spotlight style1 orient-left content-align-left image-position-center onscroll-image-fade-in">
						<div class="content">
							<h2 class="centered">Conclusion</h2>
							<p class="major">The EPHA2-GRN associates with response to HBOT in PFCD patients a priori and presents itself as a potential biomarker for remission after fistula closure surgery.</p>
						</div>
					</section>

				<!-- Seven -->
					<section class="spotlight style1 orient-left content-align-left image-position-center onscroll-image-fade-in">
						<div class="content">
							<h2 class="centered">Acknowledgements</h2>
							<p class="major">This study is supported as part of the AMFIBIO grant by The Leona M. & Harry B. Helmsley Charitable Trust.</p>
						</div>
					</section>
				<!-- Nine -->
					<section class="spotlight style1 orient-left content-align-left image-position-center onscroll-image-fade-in">
						<div class="content">
							<h2 class="centered">Refrences</h2>
							<p class="major">1. Lee, J. L., Yoon, Y. S., & Yu, C. S. (2021). Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon's Point of View. Annals of coloproctology, 37(1), 5–15. 
<br><br> 2. Lansdorp, C. A., Buskens, C. J., Gecse, K. B.,et al. (2022). Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT-TOPIC trial after 1-year follow-up. United European gastroenterology journal, 10(2), 160–168. 
<br><br> 3.  Kong, L., Pokatayev, V., Lefkovith, A., et al. (2023). The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity, 56(2), 444–458.e5. 
</p>
						</div>
					</section>

				<!-- Footer -->
					<footer class="wrapper style1 align-center">
						<div class="inner">
							<ul class="icons">
								<li><a href="https://www.gut-research.com" class="icon solid style2 major fa-desktop" target="_blank"><span class="label"></span></a></li>
								<li><a href="https://www.linkedin.com/in/ivan-cheuk-nam-fung/" class="icon brands style2 fa-linkedin-in" title="Ivan Fung's LinkedIn"><span class="label">LinkedIn</span></a></li>
								<li><a href="https://www.linkedin.com/in/roniweiss12/" class="icon brands style2 fa-linkedin-in" title="Roni Weiss's LinkedIn"><span class="label">LinkedIn</span></a></li>
								<li><a href="#" class="icon style2 fa-envelope"><span class="label">Email</span></a></li>
							</ul>
							<p>&copy; Tytgat Institute for Liver and Intestinal Research. <br> Design: <a href="https://html5up.net">HTML5 UP</a>.</p>
						</div>
					</footer>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.scrollex.min.js"></script>
			<script src="assets/js/jquery.scrolly.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
